Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

1,236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial.
Choueiri TK, Larkin J, Oya M, Thistlethwaite F, Martignoni M, Nathan P, Powles T, McDermott D, Robbins PB, Chism DD, Cho D, Atkins MB, Gordon MS, Gupta S, Uemura H, Tomita Y, Compagnoni A, Fowst C, di Pietro A, Rini BI. Choueiri TK, et al. Among authors: oya m. Lancet Oncol. 2018 Apr;19(4):451-460. doi: 10.1016/S1470-2045(18)30107-4. Epub 2018 Mar 9. Lancet Oncol. 2018. PMID: 29530667 Clinical Trial.
Brain metastasis of a papillary renal cell carcinoma, identified as type 2.
Hasegawa M, Kikuchi E, Yasumizu Y, Hattori S, Takeda T, Morita S, Kosaka T, Miyajima A, Horiguchi T, Mikami S, Oya M. Hasegawa M, et al. Among authors: oya m. Int J Clin Oncol. 2009 Jun;14(3):270-2. doi: 10.1007/s10147-008-0840-9. Epub 2009 Jul 11. Int J Clin Oncol. 2009. PMID: 19593623
Kidney Cancer Working Group report.
Naito S, Tomita Y, Rha SY, Uemura H, Oya M, Song HZ, Zhong LH, Wahid MI. Naito S, et al. Among authors: oya m. Jpn J Clin Oncol. 2010 Sep;40 Suppl 1:i51-56. doi: 10.1093/jjco/hyq127. Jpn J Clin Oncol. 2010. PMID: 20870920 Free article.
1,236 results